Temat: "Hepatitis C" - OpacWWW

Skocz do pozycji: 61.

Tytuł:: The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.
Autorzy:: Morgan B; Department of Medicine, Monash Health, Clayton, Australia. .
Lancaster R; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Boyagoda B; Central Clinical School, Monash University, Clayton, Australia.
Ananda R; Department of Medicine, Monash Health, Clayton, Australia.
Attwood LO; Central Clinical School, Monash University, Clayton, Australia.; Department of Infectious Diseases, Alfred Health, Clayton, Australia.; Monash Infectious Diseases, Monash Health, Clayton, Australia.
Jacka D; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Woolley I; Central Clinical School, Monash University, Clayton, Australia. .; Department of Infectious Diseases, Alfred Health, Clayton, Australia. .; Monash Infectious Diseases, Monash Health, Clayton, Australia. .; School of Clinical Sciences, Monash University, Clayton, Australia. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 07; Vol. 24 (1), pp. 299. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
Drug Users*
Hepatitis C*
Soft Tissue Infections*/epidemiology
Arthritis, Infectious*
Adult ; Humans ; Male ; Female ; Retrospective Studies ; Bone and Bones ; Victoria

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 62.

Tytuł:: Federal Housing Assistance and Blood Lead Levels in a Nationally Representative US Sample Age 6 and Older: NHANES, 1999-2018.
Autorzy:: Chu MT; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.; Department of Environmental and Occupational Health, Milken Institute School of Public Health, The George Washington University, Washington, District of Columbia, USA.
Fenelon A; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Adamkiewicz G; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Zota AR; Department of Environmental and Occupational Health, Milken Institute School of Public Health, The George Washington University, Washington, District of Columbia, USA.; Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.; Pokaż więcej
Źródło:: Environmental health perspectives [Environ Health Perspect] 2024 Mar; Vol. 132 (3), pp. 37004. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Public Housing*
Hepatitis C*
Humans ; United States ; Child ; Lead ; Nutrition Surveys ; Poverty

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 63.

Tytuł:: Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes.
Autorzy:: Cheng YC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 40705, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, 40227, Taiwan.
Lee TY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 40705, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.
Li YH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 40705, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan.; Department of Computer Science and Information Engineering, National Taiwan University, Taipei, 10617, Taiwan.
Lu CL; Graduate Institute of Food Safety, College of Agriculture and Natural Resources, National Chung Hsing University, Taichung, 40227, Taiwan.
Liu HC; Department of Nursing, Taichung Veterans General Hospital, Taichung, 40705, Taiwan.
Sheu ML; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, 40227, Taiwan.
Lee IT; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 40705, Taiwan. .; School of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan. .; School of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 26; Vol. 14 (1), pp. 4607. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/complications
Peripheral Arterial Disease*/complications
Hepatitis C*/complications
Humans ; Hepacivirus ; Retrospective Studies ; Albuminuria/complications ; Cross-Sectional Studies ; Reimbursement, Incentive ; Arteries ; Creatinine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 64.

Tytuł:: Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
Autorzy:: Kenfack-Momo R; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Ngounoue MD; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Kenmoe S; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Takuissu GR; Centre for Food, Food Security and Nutrition Research, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
Ebogo-Belobo JT; Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
Kengne-Ndé C; Epidemiological Surveillance, Evaluation and Research Unit, National AIDS Control Committee, Douala, Cameroon.
Mbaga DS; Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Zeuko'o Menkem E; Department of Biomedical Sciences, University of Buea, Buea, Cameroon.
Lontuo Fogang R; Department of Animal Biology, University of Dschang, Dschang, Cameroon.
Tchatchouang S; Scientific Direction, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Ndzie Ondigui JL; Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Kame-Ngasse GI; Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
Kenfack-Zanguim J; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Magoudjou-Pekam JN; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Bowo-Ngandji A; Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Mahamat M; Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.; Hemodialysis Unit, Yaoundé General Hospital, Yaoundé, Cameroon.
Nkie Esemu S; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Ndip L; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 08; Vol. 19 (2), pp. e0284169. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Hepatitis C*
Kidney Failure, Chronic*/epidemiology
Kidney Failure, Chronic*/therapy
Kidney Failure, Chronic*/etiology
Peritoneal Dialysis*/adverse effects
Humans ; Hepacivirus ; Renal Dialysis/adverse effects ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 65.

Tytuł:: Sofosbuvir Suppresses the Genome Replication of DENV1 in Human Hepatic Huh7 Cells.
Autorzy:: Kurosawa M; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
Kato F; Department of Virology III, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Hishiki T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Ito S; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
Fujisawa H; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
Yamaguchi T; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
Moriguchi M; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
Hosokawa K; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
Watanabe T; Department of Virology, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan.
Saito-Tarashima N; Graduate School of Pharmaceutical Science, Tokushima University, Tokushima 770-8505, Japan.
Minakawa N; Graduate School of Pharmaceutical Science, Tokushima University, Tokushima 770-8505, Japan.
Fujimuro M; Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 07; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Sofosbuvir*/pharmacology
Hepatitis C*
Animals ; Cricetinae ; Chlorocebus aethiops ; Humans ; Antiviral Agents/pharmacology ; Vero Cells ; RNA-Dependent RNA Polymerase ; Virus Replication ; Hepacivirus/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 66.

Tytuł:: VSpipe-GUI, an Interactive Graphical User Interface for Virtual Screening and Hit Selection.
Autorzy:: Hussain R; School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.
Hackett AS; School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.
Álvarez-Carretero S; Bristol Palaeobiology Group, School of Earth Sciences, University of Bristol, Life Sciences Building, Tyndall Avenue, Bristol BS8 1TH, UK.
Tabernero L; School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 07; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Software*
Hepatitis C*
Humans ; Proteins/chemistry ; Binding Sites ; Hepacivirus ; Ligands ; User-Computer Interface ; Molecular Docking Simulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 67.

Tytuł:: Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus.
Autorzy:: Bender D; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Koulouri A; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Wen X; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Glitscher M; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Schollmeier A; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Fernandes da Costa L; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Murra RO; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Carra GP; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Haberger V; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.
Praefcke GJK; Paul-Ehrlich-Institut, Department Haematology and Transfusion Medicine, Langen, Germany.
Hildt E; Paul-Ehrlich-Institut, Department of Virology, Langen, Germany.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2024 Feb 05; Vol. 20 (2), pp. e1011976. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Hepacivirus*/physiology
Hepatitis C*/genetics
GTP-Binding Proteins*/genetics
Humans ; Interferons ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 68.

Tytuł:: Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019.
Autorzy:: Wu XN; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China.; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Xue F; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China.
Zhang N; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China.; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Zhang W; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China.; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Hou JJ; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China.; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Lv Y; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China.; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Xiang JX; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China. .; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. .
Zhang XF; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi Province, China. .; National-Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. .; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Feb 03; Vol. 24 (1), pp. 363. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C*/complications
Non-alcoholic Fatty Liver Disease*
Perinatal Death*
Male ; Female ; Humans ; Quality-Adjusted Life Years ; Liver Cirrhosis/epidemiology ; Risk Factors ; Global Burden of Disease ; Global Health ; Incidence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 69.

Tytuł:: Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma.
Autorzy:: Kurokawa S; Laboratoy of Pathophysiology and Pharmacotherapeutics, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1 Nishikiori-kita, Tondabayashi, Osaka, 584-8540, Japan.
Kobori T; Laboratoy of Pathophysiology and Pharmacotherapeutics, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1 Nishikiori-kita, Tondabayashi, Osaka, 584-8540, Japan.
Yoneda M; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Ogawa Y; Department of Gastroenterology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajyuku, Totsuka, Yokohama, 245-8675, Japan.
Honda Y; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Kessoku T; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.; Department of Palliative Medicine, International University of Health and Welfare Narita Hospital, 852, Hatakeda, Narita, 286-8520, Japan.
Imajo K; Department of Gastroenterology, Shin-yurigaoka General Hospital, 255 Furusawatsuko, Asao, Kawasaki, 2150-0026, Japan.
Saito S; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Hotta K; Laboratoy of Pathophysiology and Pharmacotherapeutics, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1 Nishikiori-kita, Tondabayashi, Osaka, 584-8540, Japan. .; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2024 Feb 01; Vol. 24 (1), pp. 57. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Hepatitis C*/complications
Humans ; DNA Methylation ; Liver Cirrhosis/complications ; Forkhead Transcription Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 70.

Tytuł:: Risk factors for hepatitis C virus infection at a large urban emergency department.
Autorzy:: Ford JS; Department of Emergency Medicine, University of California, San Francisco, California, USA.
Hollywood E; A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, Arizona, USA.
Steuble B; Touro University of California, College of Osteopathic Medicine, Vallejo, California, USA.
Meng Z; Department of Statistics, Graduate Group of Biostatistics, University of California Davis Health, Sacramento, California, USA.
Voong S; Department of Emergency Medicine, University of California, Davis, California, USA.
Chechi T; Department of Emergency Medicine, University of California, Davis, California, USA.
Tran N; Department of Pathology and Laboratory Medicine, University of California Davis Health, Sacramento, California, USA.
May L; Department of Emergency Medicine, University of California, Davis, California, USA.; Pokaż więcej
Źródło:: Journal of viral hepatitis [J Viral Hepat] 2022 Oct; Vol. 29 (10), pp. 930-937. Date of Electronic Publication: 2022 Jul 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepacivirus*/genetics
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Adult ; Aged ; Emergency Service, Hospital ; Female ; Hepatitis C Antibodies ; Humans ; Male ; Mass Screening/methods ; Medicare ; Middle Aged ; RNA ; Retrospective Studies ; Risk Factors ; Seroepidemiologic Studies ; United States

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 71.

Tytuł:: Sociodemographic characteristics associated with hepatitis C virus infection in Vietnamese Americans: A cross-sectional analysis of community screening data.
Autorzy:: Lee AW; Department of Public Health, California State University, Fullerton, Fullerton, CA, United States of America.
Jacobs W; Department of Kinesiology, California State University, Stanislaus, Turlock, CA, United States of America.
Tran M; Department of Public Health, California State University, Fullerton, Fullerton, CA, United States of America.
Nguyen B; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.
Hua DN; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.
Ho JN; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.
Van Nguyen T; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Sep 27; Vol. 17 (9), pp. e0275210. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Hepacivirus*
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Aged ; Asian ; Cross-Sectional Studies ; Female ; Hepatitis C Antibodies ; Humans ; Male ; Prevalence ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 72.

Tytuł:: Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern.
Autorzy:: Brouard C; HIV, Hepatitis B/C and STI Unit, Santé publique France, the National Public Health Agency,, Saint-Maurice, France. .
Parenton F; Mayotte Regional Office, Santé publique France, the National Public Health Agency, Mamoudzou, France.
Youssouf H; Mayotte Regional Office, Santé publique France, the National Public Health Agency, Mamoudzou, France.
Chevaliez S; National Reference Centre for Viral Hepatitis B, C and Delta, Department of Virology, Henri Mondor University Hospital, Créteil, France.
Gordien E; National Reference Centre for Viral Hepatitis B, C and Delta, Department of Virology, Paris-Seine-Saint-Denis University Hospitals, Bobigny, France.
Jean M; Mayotte Health Regional Agency, Mamoudzou, France.
Bruyand M; HIV, Hepatitis B/C and STI Unit, Santé publique France, the National Public Health Agency,, Saint-Maurice, France.
Vaux S; HIV, Hepatitis B/C and STI Unit, Santé publique France, the National Public Health Agency,, Saint-Maurice, France.
Lot F; HIV, Hepatitis B/C and STI Unit, Santé publique France, the National Public Health Agency,, Saint-Maurice, France.
Ruello M; Survey Unit, Santé publique France, the National Public Health Agency, Saint-Maurice, France.; Pokaż więcej
Corporate Authors:: Unono Wa Maore group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2022 Aug 29; Vol. 22 (1), pp. 716. Date of Electronic Publication: 2022 Aug 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis B*/diagnosis
Hepatitis C*/epidemiology
Adolescent ; Adult ; Aged ; Biomarkers ; Comoros ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Hepatitis C Antibodies ; Hepatitis Delta Virus/genetics ; Humans ; Male ; Middle Aged ; Prevalence ; Public Health ; RNA ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 73.

Tytuł:: Hepatitis C virus screening in the 1969-1989 birth cohort: Is not enough!
Autorzy:: Viganò M; Division of Hepatology, Ospedale San Giuseppe MultiMedica IRCCS, Università degli Studi di Milano, Milan, Italy.
Cerini F; Division of Hepatology, Ospedale San Giuseppe MultiMedica IRCCS, Università degli Studi di Milano, Milan, Italy.
Ridolfo S; Division of Hepatology, Ospedale San Giuseppe MultiMedica IRCCS, Università degli Studi di Milano, Milan, Italy.
Rumi MG; Division of Hepatology, Ospedale San Giuseppe MultiMedica IRCCS, Università degli Studi di Milano, Milan, Italy.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Aug; Vol. 42 (8), pp. 1915. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:: Letter
MeSH Terms:: Hepacivirus*/genetics
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis C Antibodies ; Humans ; Mass Screening

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 74.

Tytuł:: Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China.
Autorzy:: Huang R; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, No.11 Xizhimen South Street, Beijing, 100044, China.
Shang J; Henan Provincial People's Hospital, No.7 Weiwu Street, Zhengzhou, 463599, China.
Chen H; First Hospital of Lanzhou University, No.1 Donggang west Street, Lanzhou, 730013, China.
Li J; First Affiliated Hospital with Nanjing Medical University, No.22 Hankou Street, Nanjing, 210033, China.
Xie Q; Medical College, Ruijin Hospital, Shanghai Jiaotong University, No. 573, Xujiahui Street, Shanghai, 200020, China.
Feng J; Department of Marketing, School of Business, Renmin University of China, No. 59 Zhongguancun Avenue, Beijing, 100871, China.
Wei L; Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, No.168, Litang Road, Changping District, Beijing, 102218, China.
Rao H; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, No.11 Xizhimen South Street, Beijing, 100044, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 10; Vol. 24 (1), pp. 72. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Observational Study; Multicenter Study; Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Hepatitis C*
Adult ; Male ; Humans ; Middle Aged ; Female ; Prospective Studies ; Quality of Life ; Sustained Virologic Response ; China ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 75.

Tytuł:: HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol.
Autorzy:: Arif A; Doctor's Plaza, Khayaban E Iqbal Block 9 DO Talwar, Karachi, Clifton, 75600, Pakistan. .
Hasnain A; Department of Medicine, Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Chaudhry A; Gut & Liver Center, Chaudhry Hospital and PARSA Trust Liver Clinic, Gujranwala, Pakistan.
Asim M; Dow University of Health Sciences, Karachi, Pakistan.
Shafqat MN; Gut & Liver Center, Chaudhry Hospital and PARSA Trust Liver Clinic, Gujranwala, Pakistan.
Altaf A; Dow University of Health Sciences, Karachi, Pakistan.
Saba N; Department of Medicine, Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Kemos P; Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Ansari MA; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Barnes E; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Metcalfe C; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Qureshi H; Doctor's Plaza, Khayaban E Iqbal Block 9 DO Talwar, Karachi, Clifton, 75600, Pakistan.
Hamid S; Department of Medicine, Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Choudhry AA; Gut & Liver Center, Chaudhry Hospital and PARSA Trust Liver Clinic, Gujranwala, Pakistan.
Niaz SK; Dow University of Health Sciences, Karachi, Pakistan.
Foster GR; Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Choudhry N; Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2023 Dec 18; Vol. 23 (1), pp. 2529. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Humans ; Antiviral Agents/therapeutic use ; Cohort Studies ; Hepacivirus/genetics ; Multicenter Studies as Topic ; Observational Studies as Topic ; Pakistan/epidemiology ; Prospective Studies ; Quality of Life ; Reinfection/drug therapy ; Sofosbuvir/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 76.

Tytuł:: Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Autorzy:: Sacco M; Gastro-Hepatoloy Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Ribaldone DG; Gastro-Hepatoloy Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Saracco GM; Gastro-Hepatoloy Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Dec 17; Vol. 15 (12). Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/prevention & control
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Liver Neoplasms*/prevention & control
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Metformin*/therapeutic use
Humans ; Antiviral Agents/therapeutic use ; Cohort Studies ; Prospective Studies ; Risk Reduction Behavior

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 77.

Tytuł:: Public healthcare system utilization for chronic hepatitis C infection in Vietnam.
Autorzy:: Thi Ngoc PN; Wellcome Asia Africa Programme, The Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Ho Chi Minh City, Vietnam.
My NN; The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Rasheed S; International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Khatun F; International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Van Nuil J; Wellcome Asia Africa Programme, The Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Ho Chi Minh City, Vietnam.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University, Oxford, UK.
Thanh DN; The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Mạnh HL; The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Rahman M; Wellcome Asia Africa Programme, The Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Ho Chi Minh City, Vietnam. .; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University, Oxford, UK. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Nov 16; Vol. 23 (1), pp. 802. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Hepatitis C*
Male ; Humans ; Female ; Aged ; Vietnam/epidemiology ; Hepacivirus ; Patient Acceptance of Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 78.

Tytuł:: Suppression of Innate Immunity by the Hepatitis C Virus (HCV): Revisiting the Specificity of Host-Virus Interactive Pathways.
Autorzy:: Barik S; EonBio, 3780 Pelham Drive, Mobile, AL 36619, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 08; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Hepatitis C, Chronic*
Hepatitis C*
Humans ; Hepacivirus/genetics ; Immunity, Innate ; Host Microbial Interactions ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 79.

Tytuł:: Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
Autorzy:: Eisen L
Mor Z
Madar M
Rabinovitch R
Dadon Y
Sheffer R
Kaliner E
Goldstein L; Pokaż więcej
Źródło:: Emerging infectious diseases [Emerg Infect Dis] 2023 Nov; Vol. 29 (11), pp. 2358-2361.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Prisoners*
Humans ; Hepacivirus/genetics ; Israel/epidemiology ; Prisons ; RNA

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 80.

Tytuł:: Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis.
Autorzy:: Elshafie S; Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Georgia, USA.; Central Administration for Drug Control, Egyptian Drug Authority, Cairo, Egypt.
Trivedi-Kapoor R; Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Georgia, USA.
Ebell M; Department of Epidemiology, College of Public Health, University of Georgia, Athens, Georgia, USA.; Pokaż więcej
Źródło:: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Aug; Vol. 47 (8), pp. 1149-1158. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Hepatitis C*/drug therapy
Ribavirin*/adverse effects
Sofosbuvir*/adverse effects
Antiviral Agents/adverse effects ; Drug Therapy, Combination ; Genotype ; Hepacivirus ; Hepatitis C, Chronic/drug therapy ; Humans ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hepatitis C"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji